Clinical trial
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving…
NCT00398372 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00398372 |
|---|---|
| Title | Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment |
| Official title | Le20: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment |
| Lead sponsor | Stanford University, Other |
| Collaborators | Amgen Industry National Institutes of Health (NIH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin, Lymphomas: Non-Hodgkin, Lymphomas: Non-Hodgkin Cutaneous Lymphoma, Lymphomas: Non-Hodgkin Diffuse Large B-Cell, Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell, Lymphomas: Non-Hodgkin Mantle Cell, Lymphomas: Non-Hodgkin Marginal Zone, Lymphomas: Non-Hodgkin Peripheral T-Cell, Lymphomas: Non-Hodgkin Waldenstr Macroglobulinemia |
| Intervention type | Drug |
| Interventions | Rituximab, Epratuzumab |
| Enrollment | 500 |
| Start date | Nov 1, 2000 |
| Primary completion | Jun 1, 2007 |
| Completion | Sep 1, 2009 |
| First posted | Nov 10, 2006 |
| Last update posted | Jun 2, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: